Mustang Stock Valuation


USD 0.51  0.04  8.51%   

What is the current enterprise value of Mustang Bio? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Mustang Bio, is its stock price multiplied by the total number of shares outstanding, calculating Mustang Bio's enterprise value requires a different approach. It uses Mustang Bio's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Enterprise Value is expected to rise to about 36.2 M this year, although the value of Free Cash Flow will most likely fall to (59.2 M).
Mustang Bio secures a last-minute Real Value of $2.81 per share. The latest price of the firm is $0.51. Mustang Bio is undervalued. Our model forecasts the value of Mustang Bio from analyzing the firm fundamentals such as Shares Owned by Insiders of 20.42 %, return on equity of (0.84) %, and Current Valuation of (7.47 M) as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Mustang Bio Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Mustang Bio's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Mustang Most Recent Valuation Data

Fiscal Year End
property Plant And Equipment Net
10.1 M
Enterprise Value
-7.5 M
current Deferred Revenue
270 K
net Debt
-107.6 M
Today 0.51
Please note that Mustang Bio's price fluctuation is very risky at this time. Calculation of the real value of Mustang Bio is based on 3 months time horizon. Increasing Mustang Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Mustang Bio is useful when determining the fair value of the Mustang stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Mustang Bio. Since Mustang Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mustang Stock. However, Mustang Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Mustang Bio helps investors to forecast how Mustang stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mustang Bio more accurately as focusing exclusively on Mustang Bio's fundamentals will not take into account other important factors:
Estimates (4)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
5 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mustang Bio's intrinsic value based on its ongoing forecasts of Mustang Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mustang Bio's closest peers. When choosing an evaluation method for Mustang Bio, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Mustang Bio Investments

17.52 Million

Mustang Valuation Drivers Correlation

Many accounts on the financial statements of Mustang Bio are highly interrelated and sometimes correlated. Consequently, when conducting Mustang's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Mustang
Click cells to compare fundamentals

Mustang Valuation Trend

Knowing Mustang Bio's actual value is paramount for traders to make sound investment determinations. Mustang Bio's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Mustang Bio's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Mustang Bio's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Mustang Market Cap

Mustang Bio is considered to be number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 29.11 Billion. Mustang Bio adds roughly 54.74 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Total debt  Revenue  Valuation  Workforce

Mustang Bio Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Mustang Bio's current stock value. Our valuation model uses many indicators to compare Mustang Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mustang Bio competition to find correlations between indicators driving Mustang Bio's intrinsic value. More Info.
Mustang Bio is considered to be number one stock in net asset category among related companies. It is considered to be number one stock in price to earning category among related companies . The value of Price to Earnings Ratio is estimated to slide to -2.35. The value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to slide to about (69.6 M). Comparative valuation analysis is a catch-all model that can be used if you cannot value Mustang Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mustang Bio's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mustang Bio's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mustang Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mustang Bio and how it compares across the competition.

About Mustang Bio Valuation

The stock valuation mechanism determines the current worth of Mustang Bio on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Mustang Bio. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Mustang Bio based exclusively on its fundamental and basic technical indicators. By analyzing Mustang Bio's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Mustang Bio's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mustang Bio. We calculate exposure to Mustang Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mustang Bio's related companies.
Fiscal Year End
Full Time Employees
Service Category
Employer Id Number
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Mustang Bio Current Valuation Indicators

Valuation refers to the process of determining the present value of Mustang Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mustang we look at many different elements of the entity such as Mustang's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Mustang Bio's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Mustang Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mustang Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mustang Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mustang Bio's worth.
Additionally, see Correlation Analysis. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
54.7 M
Return On Assets
Return On Equity
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Mustang Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.